BACKGROUND: Detailed information about the characteristics of smokers who do and do not participate in smoking cessation treatment is needed to improve efforts to reach, motivate, and treat smokers. PURPOSE: The aim of this study is to explore a broad range of characteristics related to participation in a smoking cessation trial. METHODS: Eligible smokers were recruited from a longitudinal birth cohort. Participants and non-participants were compared on a broad range of sociodemographics, smoking, psychiatric and substance abuse disorders, personality, and prospective measures from early childhood. Eligible smokers were compared to a matched regional subsample of the Behavioral Risk Factor Surveillance System (BRFSS). RESULTS: Few differences were observed, most of which were statistically significant but not clinically meaningful. Compared to non-participants, participants were more likely to be single, have lower income, be more nicotine-dependent, be more motivated to quit, and have higher levels of depressed mood and stress even after covariance of gender, income, and marital status. Sociodemographic differences between participants and the BRFSS sample reflect the skew toward lower socioeconomic status in the original birth cohort. CONCLUSIONS: The encouraging conclusion is that smokers who enroll in cessation trials may not differ much from non-participants. Information about treatment participants can inform the development of recruitment strategies, improve the tailoring of treatment to individual smoker profiles, help to estimate potential selection bias, and improve estimates of population impact.
BACKGROUND: Detailed information about the characteristics of smokers who do and do not participate in smoking cessation treatment is needed to improve efforts to reach, motivate, and treat smokers. PURPOSE: The aim of this study is to explore a broad range of characteristics related to participation in a smoking cessation trial. METHODS: Eligible smokers were recruited from a longitudinal birth cohort. Participants and non-participants were compared on a broad range of sociodemographics, smoking, psychiatric and substance abuse disorders, personality, and prospective measures from early childhood. Eligible smokers were compared to a matched regional subsample of the Behavioral Risk Factor Surveillance System (BRFSS). RESULTS: Few differences were observed, most of which were statistically significant but not clinically meaningful. Compared to non-participants, participants were more likely to be single, have lower income, be more nicotine-dependent, be more motivated to quit, and have higher levels of depressed mood and stress even after covariance of gender, income, and marital status. Sociodemographic differences between participants and the BRFSS sample reflect the skew toward lower socioeconomic status in the original birth cohort. CONCLUSIONS: The encouraging conclusion is that smokers who enroll in cessation trials may not differ much from non-participants. Information about treatment participants can inform the development of recruitment strategies, improve the tailoring of treatment to individual smoker profiles, help to estimate potential selection bias, and improve estimates of population impact.
Authors: Timothy B Baker; K Michael Cummings; Dorothy K Hatsukami; C Anderson Johnson; Caryn Lerman; Raymond Niaura; Stephanie S O'Malley Journal: Nicotine Tob Res Date: 2009-07-24 Impact factor: 4.244
Authors: Darren Mays; Stephen E Gilman; Richard Rende; George Luta; Kenneth P Tercyak; Raymond S Niaura Journal: Nicotine Tob Res Date: 2014-03-03 Impact factor: 4.244
Authors: Darren Mays; Stephen E Gilman; Richard Rende; George Luta; Kenneth P Tercyak; Raymond S Niaura Journal: Pediatrics Date: 2014-05-12 Impact factor: 7.124
Authors: Kristen J Polinski; Rachel Wolfe; Anne Peterson; Ashley Juhl; Marcelo Coca Perraillon; Arnold H Levinson; Tessa L Crume Journal: Public Health Nurs Date: 2019-11-06 Impact factor: 1.462
Authors: Kathryn L Taylor; Charlotte J Hagerman; George Luta; Paula G Bellini; Cassandra Stanton; David B Abrams; Jenna A Kramer; Eric Anderson; Shawn Regis; Andrea McKee; Brady McKee; Ray Niaura; Harry Harper; Michael Ramsaier Journal: Lung Cancer Date: 2017-02-15 Impact factor: 5.705
Authors: Kathryn L Taylor; Danielle E Deros; Shelby Fallon; Jennifer Stephens; Emily Kim; Tania Lobo; Kimberly M Davis; George Luta; Jinani Jayasekera; Rafael Meza; Cassandra A Stanton; Raymond S Niaura; David B Abrams; Brady McKee; Judith Howell; Michael Ramsaier; Juan Batlle; Ellen Dornelas; Vicky Parikh; Eric Anderson Journal: Contemp Clin Trials Date: 2019-05-23 Impact factor: 2.226
Authors: Stephen E Gilman; Richard Rende; Julie Boergers; David B Abrams; Stephen L Buka; Melissa A Clark; Suzanne M Colby; Brian Hitsman; Alessandra N Kazura; Lewis P Lipsitt; Elizabeth E Lloyd-Richardson; Michelle L Rogers; Cassandra A Stanton; Laura R Stroud; Raymond S Niaura Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: Lynda J Stinson; Laura R Stroud; Stephen L Buka; Charles B Eaton; Bing Lu; Raymond Niaura; Eric B Loucks Journal: Psychosom Med Date: 2015-04 Impact factor: 4.312